Even though Martin Shkreli said they would backtrack
                                
                                
                                    (Newser) -
                                    Two weeks ago, Martin Shkreli, the controversial CEO of Turing Pharmaceuticals, said that, following much public pressure,  he would dial back his company's 5,000% price hike  on a toxoplasmosis drug. But Daraprim, which jumped from $13.50 to $750 per pill, still costs the same amount,  Business Insider...